Hyperfine (HYPR)

Executive Summary

Hyperfine, Inc. is pioneering the democratization of magnetic resonance imaging with its Swoop® Portable MR Imaging® system, an ultra-low-field (0.064T), AI-powered device designed for bedside brain imaging. By eliminating the need for costly MRI suites and specialized infrastructure, the Swoop system enables diagnostic-quality imaging in diverse settings such as ICUs, emergency departments, and outpatient clinics. This innovation addresses a critical gap in healthcare access, particularly for patients who are too unstable or immobile for traditional MRI. The company's technology leverages artificial intelligence to enhance image quality and streamline workflow, potentially reducing scan times and costs. As a public company (NASDAQ: HYPR) with a market valuation of approximately $170 million, Hyperfine is positioned to capture a share of the global MRI market, which exceeds $7 billion annually, by targeting underserved segments.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for Expanded Indications (e.g., Pediatric or Spine Imaging)70% success
• Q1 2027Major Hospital System Adoption or Partnership60% success
• Q2 2026Release of Next-Generation AI Software for Improved Diagnostic Accuracy80% success